More on BMSN

- Summary
- Chart
- Profile
- Historical

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BMSN Income Statement

Click line-items for a historical chart and %
Research and Development 208.29K
General and Administrative 468.03K
Depreciation and Amortization
Consulting and Professional Fees 220.5K
Impairment of Goodwill and Intangibles
Total Costs and Expenses 911.82K
OPERATING LOSS -911.82K
Interest Expense -16.59K
Interest Income 300
Other Income
Gain on deconsolidation of Entest BioMedical
Loss on sale of Available for Sale Securities
Loss on disposal of Equipment
Other Expense
Other Losses attributable to Entest BioMedical, Inc.
Total Other Income & (Expense)
NET INCOME (LOSS)
(NET INCOME) LOSS attributable to noncontrolling interest
NET INCOME (LOSS)
Equity in NET INCOME (LOSS) of Entest BioMedical
NET INCOME (LOSS) available to Common Shareholders
BASIC AND DILUTED EARNINGS (LOSS) PER SHARE -0
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING 5.57B